Provided by Tiger Trade Technology Pte. Ltd.

RECCE PHARMACEUTICALS LTD

0.370
+0.0154.23%
Volume:97.13K
Turnover:34.86K
Market Cap:113.04M
PE:-7.16
High:0.370
Open:0.355
Low:0.345
Close:0.355
52wk High:0.730
52wk Low:0.345
Shares:305.52M
Float Shares:168.89M
Volume Ratio:1.11
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.052
EPS(LYR):-0.052
ROE:-1277.62%
ROA:-82.75%
PB:-6.76
PE(LYR):-7.16

Loading ...

Company Profile

Company Name:
RECCE PHARMACEUTICALS LTD
Exchange:
ASX
Establishment Date:
2007
Employees:
- -
Office Location:
Governor Macquarie Tower,Level 15,1 Farrer Place,Sydney,New South Wales,Australia
Zip Code:
2000
Fax:
- -
Introduction:
Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of antibiotics in Australia and the United States. Its lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.